Emerging treatments in neurogastroenterology: a multidisciplinary working group consensus statement on opioid‐induced constipation
Michael Camilleri(CSIRO Manufacturing), Gary M. Mawe(University of Vermont), Lynn R. Webster(PRA Health Sciences), Douglas A. Drossman(Rome Foundation), Andrew Davies(GW Pharmaceuticals (United Kingdom)), Gerhild Becker(University Medical Center Freiburg)
Cited by 201
Related Papers
Functional Gastroduodenal Disorders
|Gastroenterology|2006|2.4k
Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study
|Gastroenterology|2020|2.1k
Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome
|BMJ|2008|1.2k
Serotonin signalling in the gut—functions, dysfunctions and therapeutic targets
|Nature Reviews Gastroenterology & Hepatology|2013|1.1k
Intestinal barrier function in health and gastrointestinal disease
|Neurogastroenterology & Motility|2012|886